Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovica Liguori

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|September 27, 2017
E-Learning for Rare Diseases: An Example Using Fabry DiseaseChiara Cimmaruta, Ludovica Liguori, Maria Monticelli, et al.
International Journal of Molecular Sciences|August 29, 2019
β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDGMaria Monticelli, Ludovica Liguori, Mariateresa Allocca, et al.
BMC Bioinformatics|August 26, 2020
Bioinformatics tools for marine biotechnology: a practical tutorial with a metagenomic approachLudovica Liguori, Maria Monticelli, Mariateresa Allocca, et al.
Journal of Ultrasonography|May 6, 2026
Microvascular flow imaging in musculoskeletal ultrasound: from technical innovation to clinical integrationGiulia Pacella, Michela Bruno, Ludovica Liguori, et al.
Plos One|December 21, 2017
A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDGValentina Citro, Chiara Cimmaruta, Ludovica Liguori, et al.
BMC Bioinformatics|December 1, 2018
Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidaseChiara Cimmaruta, Valentina Citro, Giuseppina Andreotti, et al.
International Journal of Molecular Sciences|December 6, 2016
The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense MutationsValentina Citro, Marco Cammisa, Ludovica Liguori, et al.
International Journal of Molecular Sciences|January 17, 2020
Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense MutationsLudovica Liguori, Maria Monticelli, Mariateresa Allocca, et al.
International Journal of Molecular Sciences|January 21, 2023
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry DiseaseMaria Monticelli, Bruno Hay Mele, Mariateresa Allocca, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|July 17, 2024
The impact of the COVID-19 pandemic on academic performance among developmental age students: a systematic review with meta-analysisVincenza Gianfredi, Simona Scarioni, Luca Marchesi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|September 27, 2017
E-Learning for Rare Diseases: An Example Using Fabry DiseaseChiara Cimmaruta, Ludovica Liguori, Maria Monticelli, et al.
International Journal of Molecular Sciences|August 29, 2019
β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDGMaria Monticelli, Ludovica Liguori, Mariateresa Allocca, et al.
BMC Bioinformatics|August 26, 2020
Bioinformatics tools for marine biotechnology: a practical tutorial with a metagenomic approachLudovica Liguori, Maria Monticelli, Mariateresa Allocca, et al.
Journal of Ultrasonography|May 6, 2026
Microvascular flow imaging in musculoskeletal ultrasound: from technical innovation to clinical integrationGiulia Pacella, Michela Bruno, Ludovica Liguori, et al.
Plos One|December 21, 2017
A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDGValentina Citro, Chiara Cimmaruta, Ludovica Liguori, et al.
BMC Bioinformatics|December 1, 2018
Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidaseChiara Cimmaruta, Valentina Citro, Giuseppina Andreotti, et al.
International Journal of Molecular Sciences|December 6, 2016
The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense MutationsValentina Citro, Marco Cammisa, Ludovica Liguori, et al.
International Journal of Molecular Sciences|January 17, 2020
Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense MutationsLudovica Liguori, Maria Monticelli, Mariateresa Allocca, et al.
International Journal of Molecular Sciences|January 21, 2023
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry DiseaseMaria Monticelli, Bruno Hay Mele, Mariateresa Allocca, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|July 17, 2024
The impact of the COVID-19 pandemic on academic performance among developmental age students: a systematic review with meta-analysisVincenza Gianfredi, Simona Scarioni, Luca Marchesi, et al.
Pageof 2